Research indicates β-blockers may reduce the risk of motor diagnosis and slow symptom progression in Huntington’s disease, suggesting new management approaches.
Heart medication may slow the progression of Huntington’s disease
- Post author:
- Post published:December 4, 2024
- Post category:uncategorized